Belinda expertly navigates the complex nature of patient care for Methylation Disorders, MTHFR and Pyroluria.
In this podcast Andrew talks to Nutritionist, Claudette Casey Freeman who recently won the BioCeuticals Integrative Medicine Award (BIMA) for "Student of the Year”.
Claudette, along with juggling the many demands of new-motherhood, is also a regular contributor to many health magazines and also runs the "Nutritional Medicine Practitioners Network", a private Facebook community designed for practitioners of Nutritional Medicine to connect, network and share knowledge.
Dr Janet Schloss is a well-known and highly respected Naturopath and Nutritionist who has recently completed her PhD thesis on nutritional supplementation in Chemotherapy Induced Peripheral Neuropathy (CIPN). Indeed, so powerful were her discoveries during her research that she is now regularly asked to speak internationally to disseminate these clinical implications to improve patient care in hospitals.
According to Dr Jason Kaplan, an wholistic cardiologist from Sydney, the cholesterol story is changing.
When it comes to prevention of cardiovascular disease, cholesterol and LDL is only part of the picture. The reality is that the majority of people who are treated for heart attacks have normal cholesterol levels.
Cardiovascular disease is responsible for 11% of deaths in Australia.
In this podcast Andrew interviews interns Shannon Chafkin and Rachel Bullen on their experiences undertaking a BioCeuticals Internship.
In this podcast Andrew interviews Stacey Roberts on her approach to fertility, pregnancy and pre-eclampsia. This is vital listening for anyone wanting to lean more about optimising health for pregnancy and preventing potentially serious conditions.
Depression and anxiety disorders are exploding in prevalence. It is believed that at least 3 million Australians, at any given time, suffer from these conditions. And, while we do have standard medication for many psychiatric and psychological conditions, research shows that anywhere between 60-90% of people prescribed antidepressants fail to get a benefit that is superior to placebo. What these statistics suggest is that we are not addressing the underlying causes.